Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 18.51
0.00 (0.00%)
At close: Jan 19, 2026
Hamps Bio Revenue
Hamps Bio had revenue of 19.96M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 71.20M. In the fiscal year ending March 31, 2025, Hamps Bio had annual revenue of 66.69M with 2.99% growth.
Revenue (ttm)
71.20M
Revenue Growth
+2.99%
P/S Ratio
2.26
Revenue / Employee
949.36K
Employees
75
Market Cap
161.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 66.69M | 1.94M | 2.99% |
| Mar 31, 2024 | 64.75M | 8.97M | 16.08% |
| Mar 31, 2023 | 55.78M | 2.38M | 4.45% |
| Mar 31, 2022 | 53.40M | 15.18M | 39.71% |
| Mar 31, 2021 | 38.22M | -8.20M | -17.67% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.46B |
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 191.97M |
| Zenith Healthcare | 112.08M |
| Norris Medicines | 72.84M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.72M |